BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34439738)

  • 1. Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies.
    Cid R; BolĂ­var J
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
    Cavanagh D
    Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
    Zuckermann FA; Martin S; Husmann RJ; Brandt J
    Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Pathogenicity and Antigenicity of Avian Reoviruses and Disease Control Through Vaccination.
    Markis M
    Avian Dis; 2022 Dec; 66(4):435-442. PubMed ID: 36715476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Rabies Vaccine Design for Expression in Plants.
    Singh A; Saxena G; Verma PC
    Methods Mol Biol; 2016; 1404():547-567. PubMed ID: 27076322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
    Moyle PM
    Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
    Karch CP; Burkhard P
    Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of antiviral vaccine antigens using a silkworm-baculovirus expression system.
    Kusakabe T
    J Pharmacol Sci; 2023 Mar; 151(3):156-161. PubMed ID: 36828618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.
    Ghattas M; Dwivedi G; Lavertu M; Alameh MG
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the plant-based expression of dengue subunit vaccines.
    Yap YK; Smith DR
    Biotechnol Appl Biochem; 2010 Oct; 57(2):47-53. PubMed ID: 21110831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.
    Hemmati F; Hemmati-Dinarvand M; Karimzade M; Rutkowska D; Eskandari MH; Khanizadeh S; Afsharifar A
    Biotechnol Lett; 2022 Jan; 44(1):45-57. PubMed ID: 34837582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Development of Ruminant Vaccine Against Viral Diseases.
    Choudhury SM; Ma X; Dang W; Li Y; Zheng H
    Front Vet Sci; 2021; 8():697194. PubMed ID: 34805327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like Particle Vaccines and Platforms for Vaccine Development.
    Kheirvari M; Liu H; Tumban E
    Viruses; 2023 May; 15(5):. PubMed ID: 37243195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of oral vaccine antigens to aminopeptidase N protects pigs against pathogenic
    Van der Weken H; Jahantigh HR; Cox E; Devriendt B
    Front Immunol; 2023; 14():1192715. PubMed ID: 37457692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of Vaccination.
    Zepp F
    Methods Mol Biol; 2016; 1403():57-84. PubMed ID: 27076125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Developments in Recombinant Protein-Based Dengue Vaccines.
    Tripathi NK; Shrivastava A
    Front Immunol; 2018; 9():1919. PubMed ID: 30190720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-like particles for the prevention of human papillomavirus-associated malignancies.
    Wang JW; Roden RB
    Expert Rev Vaccines; 2013 Feb; 12(2):129-41. PubMed ID: 23414405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plants as alternative systems for production of vaccines.
    Chichester JA; Yusibov V
    Hum Vaccin; 2007; 3(4):146-8. PubMed ID: 17643065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against Infections Caused by Salmonella, Shigella, and Pathogenic Escherichia coli.
    Guzman CA; Borsutzky S; Favre D; Dietrich G
    EcoSal Plus; 2004 Dec; 1(1):. PubMed ID: 26443352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.